探索德斯敏作为杜申肌力发育不良症相关心肌病的潜在修饰剂
Brice-Emmanuel Guennec1, Yeranuhi Hovhannisyan1, Gaëlle Revet1
1Institut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France.
Acta physiologica (Oxford, England)
|October 30, 2025
概括
增加的丝状desmin在杜氏肌力发育不良 (DMD) 鼠标模型中似乎具有保护性,这表明desmin是DMD心肌病的潜在治疗标.
科学领域:
- 肌肉生理学 肌肉生理学
- 遗传性疾病 遗传性疾病
- 心血管研究的心血管研究.
背景情况:
- 杜氏肌肉发育不良 (DMD) 是一种严重的X链遗传性疾病,由于失去了素,导致肌肉逐渐退化.
- 修饰蛋白,如desmin,可能会影响DMD的进展和相关心肌病.
- 德斯明在mdx小鼠的骨肌肉中升高,这是一个轻度的DMD模型.
研究的目的:
- 为了研究德斯敏作为修饰蛋白在杜恩肌力发育不良症相关心肌病的作用.
- 为了确定改变的德斯敏水平是否会影响DMD模型中的疾病严重程度.
主要方法:
- 在mdx小鼠和GRMD狗的心脏中量化溶解和不溶解的desmin.
- 在Mdx小鼠中评估了desmin调节蛋白.
- 为表型分析,包括心脏功能和组织学,生成了德斯敏缺乏 (mdx-Des-/-) 和部分缺乏 (mdx-Des+/-) 的mdx小鼠.
主要成果:
- 在mdx小鼠中,不溶性酸化德斯增加;GRMD狗没有增加.
- 在Mdx小鼠中,德斯敏缺乏症加重了衰竭特征,心脏功能障碍和纤维化.
- 部分desmin减少取消了不溶性desmin增加,并恶化了mdx表型.
结论:
- 升高的丝状肌在mdx小鼠心脏中表现出保护作用,调节DMD心肌病变的严重程度.
- 德斯明作为DMD的修饰剂,表明其作为DMD心肌病治疗点的潜力.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Cardiomyopathy III: Hypertrophic Cardiomyopathy
387
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
387
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Cardiomyopathy I: Introduction and Classification
490
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
490
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Cardiomyopathy IV: Restrictive Cardiomyopathy
439
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
439


